Worth mentioning is that, in non-PWS individuals with obsessive compulsive disorder (OCD), changes in the oxytocin receptor have been found, and a methylation of the oxytocin receptor has even been suggested as a biomarker for the response to the treatment of OCD [94]. The gene discussed is OXTR; the disease is Prader-Willi syndrome.